• Donate
  • News + Publications
  • Careers
  • Donate
  • Contact
FNIH
Back
  • Who
    We Are
    • Board of Directors + Governance
    • Our Leadership
    • Our Team
    • Our Partners
    • Our Benefactors
    • Our History
    • Health Impact Reports
  • Our
    Programs
    • All Programs
    • Accelerating Medicines Partnership® (AMP®)
    • Accelerating COVID-19 Therapeutic Interventions & Vaccines (ACTIV)
    • Alzheimer’s Disease Neuroimaging Initiative (ADNI)
    • Biomarkers Consortium
    • GeneConvene Global Collaborative
    • Azithromycin Prevention in Labor Use Study (A-PLUS)
    • Master Protocol for Treatment of Non-Small Cell Lung Cancer (Lung-MAP)
    • Partnership For Accelerating Cancer Therapies (PACT)
    • Edmond J. Safra Family Lodge
    • Global Pandemic Treaty
    • All of Us Research Program
    • Education & Training Programs
  • Fighting
    Diseases
    • All Disease
    • Cancer
    • Cardiovascular
    • Infectious Diseases
    • Inflammation + Immunology
    • Maternal, Child + Newborn Health
    • Metabolic Disorders
    • Neuroscience
    • Rare Diseases
  • Powering
    Science
    • FNIH Awards Ceremony
    • The Lurie Prize in Biomedical Sciences
    • Trailblazer Prize for Clinician-Scientists
    • Charles A. Sanders, MD Partnership Award
    • The Deeda Blair Research Initiative for Disorders of the Brain 
    • Research Support
    • Fellowships & Training
    • Lectures
  • Patient
    Voices
Donate Partner With Us

FNIH 2022 HEALTH IMPACT REPORTBUILDING BRIDGES TO BREAKTHROUGHS

annual-block-image
particles-img blue-image
Message from Leadership
particles-img blue-image
AMP® Heart Failure
particles-img blue-image
NIMBLE
particles-img blue-image
Digital Measures Conference
particles-img blue-image
PRIORITY
particles-img blue-image
COACH
particles-img blue-image
A-PLUS Trial
particles-img blue-image
Pandemic Treaty
particles-img blue-image
Lurie Prize
particles-img blue-image
Partnership Award
particles-img blue-image
Fellowships, Lectures & Training Programs
particles-img blue-image
Trailblazer Prize
particles-img blue-image
2022 Benefactors
particles-img blue-image
2022 Board of Directors
particles-img blue-image
Facts & Figures
particles-img blue-image
Financials
  • Message from Leadership
    heading-image
    • Julie Gerberding, President and CEO
  • Accelerating New Therapies
    heading-image
    • AMP® Heart Failure
    • Digital Measures Conference
    • NIMBLE
  • Advancing Global Health
    heading-image
    • A-PLUS Trial
    • COACH
    • Pandemic Treaty
    • PRIORITY
  • Powering Science
    heading-image
    • Lurie Prize
    • Trailblazer Prize
    • Partnership Award
    • Fellowships, Lectures & Training Programs
  • People, Facts & Figures
    heading-image
    • 2022 Benefactors
    • 2022 Board of Directors
    • Facts & Figures
    • Financials
    • Previous Health Impact Reports
ftr logo
  • NIH
  • State Nonprofit Disclosures
  • Health Impact Reports
  • Contact
Subscribe To Our Newsletter
  • Privacy Policy
  • Terms of Use
  • Diversity, Equity, Inclusion, and Accessibility

© Copyright 2023 FNIH. All Rights Reserved
ACCELERATING MEDICINES PARTNERSHIP and AMP are registered service marks of the U.S. Department of Health and Human Services